Related Experiment Video
Updated: Aug 16, 2026

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Adenomas and Beyond: Colonoscopy Surveillance, Racial and Socioeconomic Disparities in Lynch Syndrome
Joseph Atarere1, Maria Malak Bilalaga1, Ramya Vasireddy1
1Department of Medicine, MedStar Union Memorial Hospital, Baltimore, Maryland.
Gastro Hep Advances
|August 15, 2026
Summary
Lynch syndrome patients with MSH6 mutations have a higher risk of developing adenomas and sessile serrated lesions (SSLs) during follow-up colonoscopies. Lower socioeconomic status is associated with increased colorectal cancer (CRC) risk at initial screening.
Area of Science:
- Gastroenterology
- Oncology
- Genetics
Background:
- Lynch syndrome, caused by mismatch repair (MMR) gene mutations, increases colorectal cancer (CRC) risk.
- Adenoma resection is a key preventive strategy for CRC.
- The occurrence of precancerous lesions like adenomas and sessile serrated lesions (SSLs) in Lynch syndrome patients requires further study.
Purpose of the Study:
- To investigate racial and socioeconomic disparities in adenoma, SSL, and CRC occurrence during initial colonoscopy in Lynch syndrome patients.
- To analyze the association between MMR gene subtypes and the development of adenomas or SSLs during follow-up colonoscopies.
Main Methods:
- Retrospective cohort study of 187 Lynch syndrome patients.
- Analysis of data from first and follow-up colonoscopies.
- Stratification by race, socioeconomic status (SES), and MMR gene subtype (MLH1, MSH2, MSH6).
Main Results:
- At first colonoscopy, 23% had SSLs, 8.6% had adenomas, and 17.1% had CRC. No racial or SES differences in adenoma/SSL occurrence were found.
- Lower SES patients had higher odds of CRC at first colonoscopy (OR: 1.24).
- MSH6 carriers showed higher odds of adenoma/SSL during follow-up compared to MLH1 and MSH2 carriers.
Conclusions:
- MSH2 carriers had the highest adenoma/SSL rates at first colonoscopy, while MSH6 carriers faced the highest risk during follow-up.
- Lower SES is linked to increased CRC risk at initial screening in Lynch syndrome.
- MMR subtype influences the risk and timing of precancerous lesion development in Lynch syndrome.
